SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000029
Filing Date
2021-03-19
Accepted
2021-03-19 16:08:36
Documents
6
Period of Report
2021-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxoffering.htm 8-K 32423
2 EX-1.1 ex11-offering.htm EX-1.1 223498
3 EX-5.1 ex51-8xkoffering.htm EX-5.1 11732
4 EX-99.1 ex991-8xkoffering.htm EX-99.1 9452
5 cooleylogov21a.jpg GRAPHIC 55818
6 phasebio2020logo1.jpg GRAPHIC 27705
  Complete submission text file 0001169245-21-000029.txt   393731
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 21758248
SIC: 2834 Pharmaceutical Preparations